# EDGAR Filing Document

**Accession Number:** 0002125725
**File Stem:** 0002125725-26-000002
**Filing Date:** 2026-4
**Character Count:** 9443
**Document Hash:** af3d9abaaf061bf6bcc81038e022f095
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002125725-26-000002.hdr.sgml**: 20260406

**ACCESSION NUMBER**: 0002125725-26-000002

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260406

**DATE AS OF CHANGE**: 20260406

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Rodda Julianne
- **CENTRAL INDEX KEY:** 0002125725

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37918
- **FILM NUMBER:** 26841901

**MAIL ADDRESS:**
- **STREET 1:** C/O IRHYTHM HOLDINGS, INC.
- **STREET 2:** 699 8TH STREET, SUITE 600
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94103
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iRhythm Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001388658
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 413421287
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 699 8TH STREET
- **STREET 2:** SUITE 600
- **CITY:** San Francisco
- **STATE:** CA
- **ZIP:** 94103
- **BUSINESS PHONE:** 415-632-5700

**MAIL ADDRESS:**
- **STREET 1:** 699 8TH STREET
- **STREET 2:** SUITE 600
- **CITY:** San Francisco
- **STATE:** CA
- **ZIP:** 94103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** iRhythm Technologies, Inc.
- **DATE OF NAME CHANGE:** 20111021

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IRhythm Technologies, Inc.
- **DATE OF NAME CHANGE:** 20110429

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IRhythm Technologies Inc
- **DATE OF NAME CHANGE:** 20070201

## Ex-24

![](poajuliannerodda_notariz001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Marc Rosenbaum (SVP, Chief Accounting Officer), Daniel Wilson (Chief Financial Officer), Patrick Murphy (Chief Business Officer and Chief Legal Officer), Susan Krause (Sr. Director, Legal), and Nicholas Rossi (Corporate Controller), and each of them, as the undersigned's true and lawful attorney- in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a representative of iRhythm Holdings, Inc. (the "Company"), (i) any and all Forms ID, and (ii) any and all Form 3, 4 or 5 reports and any amendments thereto required to be filed by the undersigned in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder with respect to transactions in the Company's securities; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID, or Form 3, 4 or 5 report and any amendments thereto and timely file such report with the U.S. Securities and Exchange Commission ("SEC"), and any stock exchange or similar authority; and (3) act as an Account Administrator, or designate such additional employees of the Company or legal counsel to the Company to act as an Account Administrator, for the undersigned's account with the EDGAR filing system maintained by the SEC including (i) managing the undersigned's EDGAR account, (ii) serving as the point of contact for questions from the SEC staff about the undersigned's EDGAR account, (iii) making EDGAR submissions on behalf of the undersigned; (iv) adding and removing other Account Administrators, Technical Administrators and Users to the undersigned's EDGAR account; (v) delegating filing authority to others (such as filing agents) on behalf of the undersigned; (vi) generating custom EDGAR filing codes for the undersigned; and (vii) performing the required annual certification of account information for the undersigned. (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned, pursuant to this Power of Attorney, shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his or her discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform each and every act and thing whatsoever requisite, necessary, and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or his or her substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that no such attorney-in-fact, in serving in such capacity at the request of the undersigned, is hereby assuming, nor is the Company hereby assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Form 3, 4 or 5 reports with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. Docusign Envelope ID: 098DF662-01A8-4C4A-AEE9-0FBA75827457

------

![](poajuliannerodda_notariz002.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26495/00600/FW/15815674.2 IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of March 23, 2026. __________________________________________ Julianne Rodda Docusign Envelope ID: 098DF662-01A8-4C4A-AEE9-0FBA75827457

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Rodda Julianne<br><sub>(Last) (First) (Middle)</sub><br>C/O IRHYTHM HOLDINGS, INC.<br>699 8TH STREET, #600<br><sub>(Street)</sub><br>SAN FRANCISCO, CA 94103<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>iRhythm Holdings, Inc. [ IRTC ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-31 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_EVP, CHIEF PEOPLE OFFICER_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 20313<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Includes 17,047 restricted stock units ("RSUs") that vest as to 3,863 RSUs on August 1, 2026, 1,074 RSUs on February 28, 2027, 4,094 RSUs on March 1, 2027, 1,074 RSUs on February 29, 2028, 2,782 RSUs on March 1, 2028, 2,781 RSUs on March 1, 2029, and 1,379 RSUs on March 1, 2030, subject to the Reporting Person continuing as a service provider through each such date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

**Remarks:**
Exhibit 24 Power of Attorney

**Signature:** /s/ Marc Rosenbaum, attorney-in-fact  
**Date:** 2026-04-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**